Jane Street’s AgomAb Therapeutics NV AGMB Stock Holding History
Bought
Maintained
Sold
Other funds holding AGMB
SL
Jane Street's AGMB Position: Q3 2026 in Review
Jane Street opened a new position in AgomAb Therapeutics NV (AGMB) in Q3 2026: 59,208 shares worth $657K. The stake represents ﹤0.01% of the portfolio and ranks #7398 among its holdings. This is a return to the name: Jane Street previously reported a position in AGMB as recently as Q1 2026.
Jane Street first reported a position in AGMB in Q1 2026 and has held it in 2 quarters since. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.
- Jane Street held 59,208 shares of AgomAb Therapeutics NV worth $657K as of Q3 2026.
- AgomAb Therapeutics NV was a new Jane Street position in Q3 2026.
- AgomAb Therapeutics NV made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #7398 holding.
- Jane Street first reported a position in AgomAb Therapeutics NV in Q1 2026 and has held it in 2 quarters since.
- 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.